Pro Share Advisors LLC Eli Lilly & CO Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pro Share Advisors LLC holds 111,951 shares of LLY stock, worth $87.9 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

111,951

Previous 120,302 6.94%

Holding current value

$87.9 Million

Previous $109 Million 8.94%

% of portfolio

0.25%

Previous 0.3%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $6.45 Million - $8.02 Million	-8,351 Reduced 6.94%	111,951 $99.2 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $5.98 Million - $7.5 Million	8,246 Added 7.36%	120,302 $109 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $1.51 Million - $2.02 Million	-2,553 Reduced 2.23%	112,056 $87.2 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $5.55 Million - $6.54 Million	-10,571 Reduced 8.44%	114,609 $66.8 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.65 Million - $2.28 Million	-3,797 Reduced 2.94%	125,180 $67.2 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $1.12 Million - $1.5 Million	3,196 Added 2.54%	128,977 $60.5 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $4.62 Million - $5.43 Million	14,880 Added 13.42%	125,781 $43.2 Million
Q4 2022 Feb 02, 2023	BUY	$321.55 - $374.67 $38,907 - $45,335	121 Added 0.11%	110,901 $40.6 Million
Q3 2022 Nov 04, 2022	SELL	$296.48 - $337.87 $3.58 Million - $4.08 Million	-12,090 Reduced 9.84%	110,780 $35.8 Million
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $13.2 Million - $15.5 Million	-47,416 Reduced 27.84%	122,870 $39.8 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $1.08 Million - $1.34 Million	-4,593 Reduced 2.63%	170,286 $48.8 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $8.74 Million - $10.8 Million	38,876 Added 28.58%	174,879 $48.3 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $595,439 - $732,771	-2,687 Reduced 1.94%	136,003 $31.4 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $4.04 Million - $5.22 Million	22,361 Added 19.22%	138,690 $31.8 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $46,666 - $60,412	-284 Reduced 0.24%	116,329 $21.7 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $395,685 - $523,586	3,033 Added 2.67%	116,613 $19.7 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $638,542 - $738,590	-4,367 Reduced 3.7%	113,580 $16.8 Million
Q2 2020 Aug 03, 2020	BUY	$136.42 - $164.18 $3.64 Million - $4.38 Million	26,694 Added 29.25%	117,947 $19.4 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $7.33 Million - $9.07 Million	-61,580 Reduced 40.29%	91,253 $12.7 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $3.16 Million - $3.92 Million	29,567 Added 23.99%	152,833 $20.1 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $541,318 - $588,815	5,069 Added 4.29%	123,266 $13.8 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $2.47 Million - $2.88 Million	-22,278 Reduced 15.86%	118,197 $13.1 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $511,580 - $602,167	-4,596 Reduced 3.17%	140,475 $18.2 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $493,705 - $553,099	4,662 Added 3.32%	145,071 $16.8 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $1.03 Million - $1.28 Million	-11,962 Reduced 7.85%	140,409 $15.1 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $3.03 Million - $3.47 Million	-39,971 Reduced 20.78%	152,371 $13 Million
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $390,047 - $460,425	5,256 Added 2.81%	192,342 $14.9 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $3.96 Million - $4.25 Million	48,313 Added 34.81%	187,086 $15.8 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $3.17 Million - $3.52 Million	41,190 Added 42.21%	138,773 $11.9 Million
Q2 2017 Aug 11, 2017	BUY	N/A	97,583	97,583 $8.03 Million

Others Institutions Holding LLY

# of Institutions

4,033

Shares Held

737M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $746B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Eli Lilly & CO Transaction History